Spotlight
What clinical research is changing right now — in plain language.
First spotlights are on their way.
Plain-language stories about trial results, the labs behind them, and the people taking part — curated by the Concord team. In the meantime, 2,110 trials are actively recruiting across Canada.
Newly added recruiting trials
Non-ablative Oligofractionated Radiation Therapy Before Surgical Transplantation As Radiovaccination
Transplant-Related Lung Cancer · Marc de Perrot
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Lupus Erythematosus, Systemic · AstraZeneca
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure · Colorado Prevention Center
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Heart Failure With Reduced Ejection Fraction · Novartis Pharmaceuticals
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure · Colorado Prevention Center
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Systemic Lupus Erythematosus (With and Without Nephritis) · Allogene Therapeutics
Where research is most active
Concord provides information support only. Trial listings come from public registries; nothing here is a claim about the efficacy of any treatment.